查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球Peptide合成市場預測按試劑（樹脂,氨基酸,染料）,設備（Peptide合成儀,色譜儀,凍乾機）,技術（固相,液相,混合）,服務,最終用戶（製藥,生物技術,CRO）,地區至2028
市場調查報告書
商品編碼
1309732

全球Peptide合成市場預測按試劑（樹脂,氨基酸,染料）,設備（Peptide合成儀,色譜儀,凍乾機）,技術（固相,液相,混合）,服務,最終用戶（製藥,生物技術,CRO）,地區至2028

Peptide Synthesis Market by Reagents (Resins, Amino Acid, Dyes), Equipment (Peptide Synthesizer, Chromatography, Lyophilizer), Technology (Solid-phase, Solution-phase, Hybrid), Services, End User (Pharma, Biotech, CRO), Region - Global Forecast to 2028
出版日期: | 出版商: MarketsandMarkets | 英文 248 Pages | 訂單完成後即時交付

價格
簡介目錄

全球Peptide合成市場規模預計在預測期內以 7.4% 的複合年增長率增長，從 2023 年的 6.01 億美元增至 2028 年的 8.59 億美元。

Peptide合成領域的進步以及Peptide合成所用試劑需求增加等因素將對Peptide合成產品和服務的增長產生積極影響，預計將實現穩定增長。

“試劑細分市場將在預測期內實現最高增長率”

按產品和服務劃分，試劑細分市場將在 2022 年以最高速度增長。 Peptide合成試劑市場進一步細分為樹脂,氨基酸,偶聯試劑,染料/熒光標記試劑和其他試劑（保護試劑,接頭,緩衝液,溶劑,溶液等）。 對大量試劑的需求以及Peptide在治療,藥物設計和基因合成中的使用不斷增加是預測該細分市場增長的一些因素。

“亞太地區增長速度更快”

從各地區Peptide合成市場來看，2022年，北美將佔據壓倒性份額。 該地區的主導地位歸因於多種因素，包括該地區大公司的存在以及開發新靶向療法的持續研究工作。 由於各種因素，例如個性化醫療意識的提高,該地區政府對仿製藥的舉措的增加以及Peptide合成市場新進入者的出現，亞太地區可能會以更快的速度增長。

內容

第一章簡介

第 2 章研究方法

第 3 章執行摘要

第 4 章重要考慮因素

第五章市場概述

  • 簡介
  • 市場動態
    • 驅動程序
    • 制約因素
    • 機會
    • 任務
  • 範圍/場景
  • 影響客戶業務的趨勢/干擾
  • 價值鏈分析
  • 技術分析
  • 專利分析
  • 多Peptide合成市場生態系統分析
  • 波特五力分析
  • 監管分析
  • 重大會議和活動（2023 年）
  • 主要利益相關者和採購標準

第 6 章Peptide合成市場：按產品/服務

  • 簡介
  • 試劑
    • 樹脂
    • 氨基酸
    • 偶聯劑
    • 染料和熒光標記試劑
    • 其他試劑
  • 設備
    • 多Peptide合成儀
    • 色譜設備
    • 冷凍乾燥機
  • 服務

第 7 章：Peptide合成市場：按技術劃分

  • 簡介
  • 固相Peptide合成
  • 液相Peptide合成
  • 雜交/重組技術

第 8 章：Peptide合成市場：按最終用戶劃分

  • 簡介
  • 製藥和生物技術公司
  • CDMO（合同研究與製造組織）/CRO（合同研究與開發組織）
  • 學術研究所

第 9 章：Peptide合成市場：按地區

  • 簡介
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他拉丁美洲地區
  • 中東和非洲

第 10 章競爭格局

  • 簡介
  • 主要公司採取的策略
  • 收入份額分析
  • 市場份額分析
  • 公司評估矩陣：主要公司
  • 競爭基準：前 25 名公司
  • 業務評估象限：初創企業/中小企業
  • 競爭基準：初創企業/中小企業
  • 競爭場景和趨勢

第 11 章公司簡介

  • 主要公司
    • THERMO FISHER SCIENTIFIC
    • MERCK KGAA
    • GENSCRIPT BIOTECH CORPORATION
    • BACHEM HOLDING AG
    • KANEKA CORPORATION
    • BIOTAGE AB
    • SYNGENE INTERNATIONAL LIMITED
    • MESA LABORATORIES, INC.
    • CEM CORPORATION
    • PROTEOGENIX
    • BIO-SYNTHESIS INC.
    • DALTON PHARMA SERVICES
    • AAPPTEC
    • VIVITIDE
    • ANYGEN CO., LTD.
  • 其他企業
    • CSBIO
    • ADVANCED CHEMTECH
    • LUXEMBOURG BIO TECHNOLOGIES LTD.
    • JPT PEPTIDE TECHNOLOGIES GMBH
    • AMBIOPHARM INC.
    • AURIGENE PHARMACEUTICAL SERVICES LTD.
    • CORDENPHARMA INTERNATIONAL
    • CHEMPEP INC.
    • CPC SCIENTIFIC INC.
    • PUROLITE PVT. LTD.

第12章 附錄

簡介目錄
Product Code: BT 6462

The global peptide synthesis market size is projected to reach USD 859 million by 2028 from 601 million in 2023, at a CAGR of 7.4 % during the forecast period. Factors such advancement in the field of peptide synthesis, and increased demand for reagents used in peptide synthesis is expected to experience steady growth leading to positive impact on the growth of peptide synthesis products & services.

"The reagents segment accounted for the highest growth rate in the peptide synthesis market, by product & service, during the forecast period"

In 2022, the reagents segment accounted for the highest growth rate. The peptide synthesis reagents market is further segmented into resins, amino acids, coupling reagents, dyes and fluorescent labeling reagents, and other reagents (such as protecting reagents, linkers, buffers, solvents, and solutions). The requirement of reagents in bulk quantities, expanding applications of peptides in therapeutics, drug design, and gene synthesis are some of the factors anticipated to project the growth of the segment.

"Asia Pacific region is likely to grow at a faster pace."

The peptide synthesis market is divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2022, North America accounted for the dominant share of the peptide synthesis market. The dominance of the region is attributable to various factors such as the presence of leading players in the region coupled with the ongoing research activities of developing new targeted therapies. Asia Pacific region is likely to grow at a faster pace owing to various factors such as the growing awareness of personalized therapeutics, rising government initiatives for generic medicines in the region, and the emergence of new market players in the peptide synthesis market.

The primary interviews conducted for this report can be categorized as follows:

  • By Respondent: Supply Side- 70%, and Demand Side - 30%
  • By Designation (Supply Side): Managers - 45%, CXOs & Directors - 30%, Executives- 25%
  • By Region: North America -40%, Europe -25%, Asia-Pacific -20%, Latin America -10%, and Middle East and Africa -5%

Lists of Companies Profiled in the Report:

  • Bachem Holding AG (Switzerland)
  • Thermo Fisher Scientific, Inc. (US)
  • Merck KGaA (Germany)
  • GenScript Biotech Corporation (China)
  • Kaneka Corporation (Japan)
  • Biotage AB (Sweden)
  • Syngene International Ltd. (India)
  • Mesa Laboratories Inc. (US)
  • CEM Corporation (US)
  • ProteoGenix (France)
  • Bio-Synthesis Inc. (US)
  • Dalton Pharma Services (Canada)
  • AAPPTec (US)
  • vivitide (US)
  • AnyGen Co., Ltd. (South Korea)
  • CSBio (US)
  • Advanced Chemtech (US)
  • Luxembourg Bio Technologies Ltd. (Israel)
  • JPT Peptide Technologies GmbH (Germany)
  • AmbioPharm Inc. (US)
  • Aurigene Pharmaceutical Services Ltd. (India)
  • Corden Pharma International (Germany)
  • ChemPep Inc. (US)
  • CPC Scientific Inc. (US)
  • Purolite Pvt Ltd. (US)

Research Coverage:

This report provides a detailed picture of the peptide synthesis market. It aims at estimating the size and future growth potential of the market across different segments, such the product, application, end user and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles recent developments and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall peptide synthesis market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

  • Analysis of key drivers (the increasing use of peptides in pharmaceutical drugs, increase in research activities and availability of funding for R&D, and the development of advanced automated peptide synthesizers), restraints (Lack of a unified set of regulations for therapeutic peptides, High cost of instruments), opportunities (Emerging markets in the Asia Pacific region, Development of personalized medicines), and challenges (Issues associated with the route of administration of peptide drugs, Addressing environmental impact of chemical synthesis of peptides.)
  • Product & Service Development/Innovation: Detailed insights on newly launched products, and technological assessment of the peptide synthesis market.
  • Market Development: Comprehensive information about lucrative markets - the report analyses the peptide synthesis market across varied regions.
  • Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the peptide synthesis market.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and product & service offerings of leading players like GenScript Biotech Corporation (China), Thermo Fisher Scientific, Inc. (US), Bachem Holding AG (Switzerland), Kaneka Corporation (US), Inc.and Merck KGaA (Germany) and among others in the peptide synthesis market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED
  • 1.4 CURRENCY CONSIDERED
  • 1.5 LIMITATIONS
  • 1.6 STAKEHOLDERS
  • 1.7 SUMMARY OF CHANGES
    • 1.7.1 RECESSION IMPACT

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 1 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
    • 2.1.2 PRIMARY DATA
    • FIGURE 2 PEPTIDE SYNTHESIS MARKET: BREAKDOWN OF PRIMARIES
  • 2.2 MARKET SIZE ESTIMATION
    • FIGURE 3 PEPTIDE SYNTHESIS MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2022
    • FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE SHARE ANALYSIS), 2022
    • FIGURE 5 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC, INC.: REVENUE SHARE ANALYSIS, 2022
    • 2.2.1 INSIGHTS FROM PRIMARIES
    • FIGURE 6 MARKET VALIDATION FROM PRIMARY EXPERTS
    • 2.2.2 SEGMENT ASSESSMENT (BY PRODUCT, APPLICATION, AND END USER)
    • FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • 2.3 GROWTH RATE ASSUMPTIONS
    • FIGURE 8 PEPTIDE SYNTHESIS MARKET: CAGR PROJECTIONS, 2023-2028
    • FIGURE 9 PEPTIDE SYNTHESIS MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, CHALLENGES, AND OPPORTUNITIES
  • 2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
    • FIGURE 10 DATA TRIANGULATION METHODOLOGY
  • 2.5 STUDY ASSUMPTIONS
  • 2.6 RISK ANALYSIS
  • 2.7 IMPACT OF ECONOMIC RECESSION ON PEPTIDE SYNTHESIS MARKET
    • TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021-2028 (% GROWTH)
    • TABLE 2 US HEALTH EXPENDITURE, 2019-2022 (USD MILLION)
    • TABLE 3 US HEALTH EXPENDITURE, 2023-2027 (USD MILLION)

3 EXECUTIVE SUMMARY

    • FIGURE 11 PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD MILLION)
    • FIGURE 12 PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION)
    • FIGURE 13 PEPTIDE SYNTHESIS MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
    • FIGURE 14 PEPTIDE SYNTHESIS MARKET: GEOGRAPHICAL SNAPSHOT

4 PREMIUM INSIGHTS

  • 4.1 PEPTIDE SYNTHESIS MARKET OVERVIEW
    • FIGURE 15 INCREASING USE OF PEPTIDES IN PHARMACEUTICAL DRUGS AND GROWING RESEARCH ACTIVITIES TO DRIVE MARKET GROWTH
  • 4.2 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE AND COUNTRY (2022)
    • FIGURE 16 REAGENTS SEGMENT ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN PEPTIDE SYNTHESIS MARKET IN 2022
  • 4.3 PEPTIDE SYNTHESIS MARKET SHARE, BY TECHNOLOGY (2022)
    • FIGURE 17 SOLID-PHASE PEPTIDE SYNTHESIS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
  • 4.4 PEPTIDE SYNTHESIS MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
    • FIGURE 18 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES WILL CONTINUE TO DOMINATE MARKET IN 2028
  • 4.5 PEPTIDE SYNTHESIS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 19 ASIA PACIFIC COUNTRIES TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 20 MARKET DYNAMICS: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • TABLE 4 PEPTIDE SYNTHESIS MARKET: IMPACT ANALYSIS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing use of peptides in pharmaceutical drugs
    • TABLE 5 PEPTIDE-BASED DRUGS APPROVED BY FOOD AND DRUG ADMINISTRATION
    • TABLE 6 KEY SYNTHETIC PEPTIDES IN DEVELOPMENT FOR COVID-19
      • 5.2.1.2 Increase in research activities and availability of funding for R&D
    • FIGURE 21 RISE IN GLOBAL PHARMACEUTICAL R&D SPENDING, 2012-2026
      • 5.2.1.3 Development of advanced automated peptide synthesizers
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Lack of unified set of regulations for therapeutic peptides
      • 5.2.2.2 High cost of instruments
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Emerging markets in Asia Pacific region
      • 5.2.3.2 Development of personalized medicines
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Issues associated with route of administration of peptide drugs
      • 5.2.4.2 Addressing environmental impact of chemical synthesis of peptides
  • 5.3 RANGES/SCENARIOS
    • FIGURE 22 SPECTRUM OF SCENARIOS BASED ON IMPACT OF UNCERTAINTIES ON GROWTH OF PEPTIDE SYNTHESIS MARKET
  • 5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.5 VALUE CHAIN ANALYSIS
    • FIGURE 23 VALUE CHAIN ANALYSIS OF PEPTIDE SYNTHESIS MARKET: RESEARCH AND MANUFACTURING PHASE CONTRIBUTES MAXIMUM VALUE
  • 5.6 TECHNOLOGY ANALYSIS
    • TABLE 7 COMPARISON OF PEPTIDE SYNTHESIS TECHNOLOGIES
  • 5.7 PATENT ANALYSIS
    • FIGURE 24 PATENT APPLICATIONS FOR PEPTIDE SYNTHESIS MARKET, JUNE 2013-JUNE 2023
    • TABLE 8 INDICATIVE LIST OF PATENTS IN PEPTIDE SYNTHESIS MARKET
  • 5.8 ECOSYSTEM ANALYSIS OF PEPTIDE SYNTHESIS MARKET
    • TABLE 9 SUPPLY CHAIN ECOSYSTEM
  • 5.9 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 10 PEPTIDE SYNTHESIS MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.9.1 THREAT OF NEW ENTRANTS
    • 5.9.2 THREAT OF SUBSTITUTES
    • 5.9.3 BARGAINING POWER OF SUPPLIERS
    • 5.9.4 BARGAINING POWER OF BUYERS
    • 5.9.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.10 REGULATORY ANALYSIS
    • 5.10.1 REGULATIONS FOR PEPTIDE-BASED DRUGS
    • 5.10.2 REGULATIONS FOR PEPTIDE SYNTHESIS PRODUCTS
    • 5.10.3 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 11 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 12 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 13 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.11 KEY CONFERENCES AND EVENTS IN 2023
    • TABLE 14 PEPTIDE SYNTHESIS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS IN 2023
  • 5.12 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • FIGURE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF PEPTIDE SYNTHESIS PRODUCTS
    • 5.12.2 BUYING CRITERIA
    • FIGURE 26 KEY BUYING CRITERIA FOR END USERS

6 PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE

  • 6.1 INTRODUCTION
    • TABLE 15 PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • 6.2 REAGENTS
    • TABLE 16 PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 17 PEPTIDE SYNTHESIS REAGENTS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 18 NORTH AMERICA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 19 EUROPE: PEPTIDE SYNTHESIS REAGENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 20 ASIA PACIFIC: PEPTIDE SYNTHESIS REAGENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 21 LATIN AMERICA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.2.1 RESINS
      • 6.2.1.1 Increasing adoption of solid-phase peptide synthesis technology to boost market
    • TABLE 22 PEPTIDE SYNTHESIS MARKET FOR RESINS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 23 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR RESINS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 24 EUROPE: PEPTIDE SYNTHESIS MARKET FOR RESINS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 25 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR RESINS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 26 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR RESINS, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.2.2 AMINO ACIDS
      • 6.2.2.1 Amino acids play crucial role in synthesis of peptides
    • TABLE 27 PEPTIDE SYNTHESIS MARKET FOR AMINO ACIDS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 28 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR AMINO ACIDS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 29 EUROPE: PEPTIDE SYNTHESIS MARKET FOR AMINO ACIDS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 30 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR AMINO ACIDS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 31 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR AMINO ACIDS, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.2.3 COUPLING REAGENTS
      • 6.2.3.1 Vital role of coupling reagents in peptide bond formation to boost market
    • TABLE 32 PEPTIDE SYNTHESIS MARKET FOR COUPLING REAGENTS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 33 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR COUPLING REAGENTS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 34 EUROPE: PEPTIDE SYNTHESIS MARKET FOR COUPLING REAGENTS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 35 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR COUPLING REAGENTS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 36 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR COUPLING REAGENTS, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.2.4 DYES & FLUORESCENT LABELING REAGENTS
      • 6.2.4.1 Fluorescent labeling reagents play crucial role in understanding success rate of peptide synthesis reactions
    • TABLE 37 PEPTIDE SYNTHESIS MARKET FOR DYES & FLUORESCENT LABELING REAGENTS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 38 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR DYES & FLUORESCENT LABELING REAGENTS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 39 EUROPE: PEPTIDE SYNTHESIS MARKET FOR DYES & FLUORESCENT LABELING REAGENTS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 40 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR DYES & FLUORESCENT LABELING REAGENTS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 41 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR DYES & FLUORESCENT LABELING REAGENTS, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.2.5 OTHER REAGENTS
    • TABLE 42 PEPTIDE SYNTHESIS MARKET FOR OTHER REAGENTS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 43 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR OTHER REAGENTS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 44 EUROPE: PEPTIDE SYNTHESIS MARKET FOR OTHER REAGENTS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 45 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR OTHER REAGENTS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 46 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR OTHER REAGENTS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 6.3 EQUIPMENT
    • TABLE 47 PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 48 PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 49 NORTH AMERICA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 50 EUROPE: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 51 ASIA PACIFIC: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 52 LATIN AMERICA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.3.1 PEPTIDE SYNTHESIZERS
      • 6.3.1.1 Rising automation in peptide synthesizers to drive market growth
    • TABLE 53 MAJOR PEPTIDE SYNTHESIZERS AVAILABLE IN MARKET
    • TABLE 54 PEPTIDE SYNTHESIS MARKET FOR PEPTIDE SYNTHESIZERS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 55 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE SYNTHESIZERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 56 EUROPE: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE SYNTHESIZERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 57 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE SYNTHESIZERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 58 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE SYNTHESIZERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.3.2 CHROMATOGRAPHY EQUIPMENT
      • 6.3.2.1 Reverse-phase HPLC used for purification of synthetic peptides to promote market growth
    • TABLE 59 PEPTIDE SYNTHESIS MARKET FOR CHROMATOGRAPHY EQUIPMENT, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 60 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR CHROMATOGRAPHY EQUIPMENT, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 61 EUROPE: PEPTIDE SYNTHESIS MARKET FOR CHROMATOGRAPHY EQUIPMENT, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 62 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR CHROMATOGRAPHY EQUIPMENT, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 63 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR CHROMATOGRAPHY EQUIPMENT, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.3.3 LYOPHILIZERS
      • 6.3.3.1 Lyophilization to enable longer shelf life and easy transportation of peptides
    • TABLE 64 PEPTIDE SYNTHESIS MARKET FOR LYOPHILIZERS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 65 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR LYOPHILIZERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 66 EUROPE: PEPTIDE SYNTHESIS MARKET FOR LYOPHILIZERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 67 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR LYOPHILIZERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 68 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR LYOPHILIZERS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 6.4 SERVICES
    • 6.4.1 RISE IN RESEARCH ACTIVITIES IN PROTEOMICS, GENOMICS, AND PEPTIDE THERAPEUTICS TO DRIVE MARKET
    • TABLE 69 PEPTIDE SYNTHESIS SERVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 70 NORTH AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 71 EUROPE: PEPTIDE SYNTHESIS SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 72 ASIA PACIFIC: PEPTIDE SYNTHESIS SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 73 LATIN AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)

7 PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY

  • 7.1 INTRODUCTION
    • TABLE 74 PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • 7.2 SOLID-PHASE PEPTIDE SYNTHESIS
    • 7.2.1 EASE OF USE OF SOLID-PHASE PEPTIDE SYNTHESIS TECHNOLOGY TO DRIVE GROWTH
    • TABLE 75 SOLID-PHASE PEPTIDE SYNTHESIS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 76 NORTH AMERICA: SOLID-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 77 EUROPE: SOLID-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 78 ASIA PACIFIC: SOLID-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 79 LATIN AMERICA: SOLID-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.3 SOLUTION-PHASE PEPTIDE SYNTHESIS
    • 7.3.1 ABILITY TO PRODUCE LARGE QUANTITIES OF HIGH-QUALITY PEPTIDES COST-EFFECTIVELY TO DRIVE GROWTH
    • TABLE 80 SOLUTION-PHASE PEPTIDE SYNTHESIS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 81 NORTH AMERICA: SOLUTION-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 82 EUROPE: SOLUTION-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 83 ASIA PACIFIC: SOLUTION-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 84 LATIN AMERICA: SOLUTION-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.4 HYBRID & RECOMBINANT TECHNOLOGY
    • 7.4.1 PRODUCTION OF PEPTIDES WITH HIGH COMPLEXITY TO BOOST MARKET
    • TABLE 85 HYBRID & RECOMBINANT PEPTIDE SYNTHESIS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 86 NORTH AMERICA: HYBRID & RECOMBINANT PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 87 EUROPE: HYBRID & RECOMBINANT PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 88 ASIA PACIFIC: HYBRID & RECOMBINANT PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 89 LATIN AMERICA: HYBRID & RECOMBINANT PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)

8 PEPTIDE SYNTHESIS MARKET, BY END USER

  • 8.1 INTRODUCTION
    • TABLE 90 PEPTIDE SYNTHESIS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 8.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    • 8.2.1 USE OF PEPTIDES IN DRUG DEVELOPMENT APPLICATIONS TO DRIVE GROWTH
    • TABLE 91 PEPTIDE SYNTHESIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 92 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 93 EUROPE: PEPTIDE SYNTHESIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 94 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 95 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.3 CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS AND CONTRACT RESEARCH ORGANIZATIONS (CDMOS AND CROS)
    • 8.3.1 INCREASING DEMAND FOR COST-EFFECTIVE PEPTIDE SYNTHESIS SERVICES TO DRIVE GROWTH
    • TABLE 96 PEPTIDE SYNTHESIS MARKET FOR CDMOS AND CROS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 97 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR CDMOS AND CROS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 98 EUROPE: PEPTIDE SYNTHESIS MARKET FOR CDMOS AND CROS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 99 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR CDMOS AND CROS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 100 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR CDMOS AND CROS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.4 ACADEMIC & RESEARCH INSTITUTES
    • 8.4.1 INCREASE IN FINANCIAL AND REGULATORY SUPPORT FOR RESEARCH TO BOOST MARKET GROWTH
    • TABLE 101 PEPTIDE SYNTHESIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 102 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 103 EUROPE: PEPTIDE SYNTHESIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 104 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 105 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)

9 PEPTIDE SYNTHESIS MARKET, BY REGION

  • 9.1 INTRODUCTION
    • TABLE 106 PEPTIDE SYNTHESIS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 9.2 NORTH AMERICA
    • FIGURE 27 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET SNAPSHOT
    • TABLE 107 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 108 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 109 NORTH AMERICA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 110 NORTH AMERICA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 111 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 112 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.2.1 US
      • 9.2.1.1 US to dominate North American peptide synthesis market during forecast period
    • TABLE 113 US: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 114 US: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 115 US: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 116 US: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 117 US: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.2.2 CANADA
      • 9.2.2.1 Availability of research funding in Canada to drive market growth
    • TABLE 118 CANADA: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 119 CANADA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 120 CANADA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 121 CANADA: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 122 CANADA: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.3 EUROPE
    • TABLE 123 EUROPE: PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 124 EUROPE: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 125 EUROPE: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 126 EUROPE: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 127 EUROPE: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 128 EUROPE: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.3.1 GERMANY
      • 9.3.1.1 Government initiatives and rise in funding for peptide synthesis to propel growth
    • TABLE 129 GERMANY: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 130 GERMANY: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 131 GERMANY: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 132 GERMANY: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 133 GERMANY: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021-2028 USD MILLION)
    • 9.3.2 UK
      • 9.3.2.1 Growth in life science research to drive market growth
    • TABLE 134 UK: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 135 UK: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 136 UK: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 137 UK: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 138 UK: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.3.3 FRANCE
      • 9.3.3.1 Government funding for proteomics and genomics research to propel market growth
    • TABLE 139 FRANCE: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 140 FRANCE: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 141 FRANCE: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 142 FRANCE: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 143 FRANCE: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.3.4 ITALY
      • 9.3.4.1 Increase in life science research to boost market growth in Italy
    • TABLE 144 ITALY: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 145 ITALY: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 146 ITALY: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 147 ITALY: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 148 ITALY: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021-2028 USD MILLION)
    • 9.3.5 SPAIN
      • 9.3.5.1 Rising focus on research and innovation to support market growth
    • TABLE 149 SPAIN: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 150 SPAIN: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 151 SPAIN: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 152 SPAIN: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 153 SPAIN: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021-2028 USD MILLION)
    • 9.3.6 REST OF EUROPE
    • TABLE 154 REST OF EUROPE: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 155 REST OF EUROPE: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 156 REST OF EUROPE: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 157 REST OF EUROPE: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 158 REST OF EUROPE: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.4 ASIA PACIFIC
    • FIGURE 28 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET SNAPSHOT
    • TABLE 159 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 160 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 161 ASIA PACIFIC: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 162 ASIA PACIFIC: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 163 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 164 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.4.1 CHINA
      • 9.4.1.1 China to register highest growth rate due to increase in investments in R&D
    • TABLE 165 CHINA: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 166 CHINA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 167 CHINA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 168 CHINA: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 169 CHINA: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.4.2 JAPAN
      • 9.4.2.1 Rise in collaborations between companies in Japan to propel market growth
    • TABLE 170 JAPAN: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 171 JAPAN: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 172 JAPAN: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 173 JAPAN: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 174 JAPAN: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.4.3 INDIA
      • 9.4.3.1 Government support for scientific research to drive market growth
    • TABLE 175 INDIA: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 176 INDIA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 177 INDIA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 178 INDIA: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 179 INDIA: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.4.4 SOUTH KOREA
      • 9.4.4.1 Growing research efforts in biopharmaceutical sector to boost market growth
    • TABLE 180 SOUTH KOREA: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 181 SOUTH KOREA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 182 SOUTH KOREA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 183 SOUTH KOREA: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 184 SOUTH KOREA: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.5 REST OF ASIA PACIFIC
    • TABLE 185 REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 186 REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 187 REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 188 REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 189 REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.6 LATIN AMERICA
    • TABLE 190 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 191 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 192 LATIN AMERICA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 193 LATIN AMERICA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 194 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 195 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.6.1 BRAZIL
      • 9.6.1.1 Rising government investments in research to propel market growth
    • TABLE 196 BRAZIL: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 197 BRAZIL: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 198 BRAZIL: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 199 BRAZIL: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 200 BRAZIL: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.6.2 MEXICO
      • 9.6.2.1 Synthetic biology research advancements to drive market growth
    • TABLE 201 MEXICO: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 202 MEXICO: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 203 MEXICO: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 204 MEXICO: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 205 MEXICO: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.6.3 REST OF LATIN AMERICA
    • TABLE 206 REST OF LATIN AMERICA: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 207 REST OF LATIN AMERICA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 208 REST OF LATIN AMERICA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 209 REST OF LATIN AMERICA: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 210 REST OF LATIN AMERICA: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.6.4 MIDDLE EAST & AFRICA
      • 9.6.4.1 Growing pharmaceutical & biotechnology industries and increasing R&D activities to drive market growth
    • TABLE 211 MIDDLE EAST & AFRICA: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 212 MIDDLE EAST & AFRICA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 213 MIDDLE EAST & AFRICA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 214 MIDDLE EAST & AFRICA: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 215 MIDDLE EAST & AFRICA: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021-2028 (USD MILLION)

10 COMPETITIVE LANDSCAPE

  • 10.1 INTRODUCTION
  • 10.2 STRATEGIES ADOPTED BY KEY PLAYERS
    • FIGURE 29 PEPTIDE SYNTHESIS MARKET: STRATEGIES ADOPTED BY KEY PLAYERS
  • 10.3 REVENUE SHARE ANALYSIS
    • FIGURE 30 REVENUE ANALYSIS OF KEY PLAYERS, 2020-2022
  • 10.4 MARKET SHARE ANALYSIS
    • FIGURE 31 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2022
    • TABLE 216 PEPTIDE SYNTHESIS MARKET: DEGREE OF COMPETITION
  • 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS
    • FIGURE 32 PEPTIDE SYNTHESIS MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2022
    • 10.5.1 STARS
    • 10.5.2 EMERGING LEADERS
    • 10.5.3 PERVASIVE PLAYERS
    • 10.5.4 PARTICIPANTS
  • 10.6 COMPETITIVE BENCHMARKING OF TOP 25 PLAYERS
    • 10.6.1 PRODUCT FOOTPRINT OF COMPANIES (25 COMPANIES)
    • TABLE 217 PEPTIDE SYNTHESIS MARKET: PRODUCT FOOTPRINT ANALYSIS OF KEY PLAYERS
    • 10.6.2 REGIONAL FOOTPRINT OF COMPANIES (25 COMPANIES)
    • TABLE 218 PEPTIDE SYNTHESIS MARKET: REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS
  • 10.7 COMPANY EVALUATION QUADRANT: START-UPS/SMES
    • FIGURE 33 PEPTIDE SYNTHESIS MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022
    • 10.7.1 PROGRESSIVE COMPANIES
    • 10.7.2 STARTING BLOCKS
    • 10.7.3 RESPONSIVE COMPANIES
    • 10.7.4 DYNAMIC COMPANIES
  • 10.8 COMPETITIVE BENCHMARKING OF START-UP/SME PLAYERS
    • TABLE 219 PEPTIDE SYNTHESIS MARKET: DETAILED LIST OF KEY START-UP/SME PLAYERS
    • TABLE 220 PEPTIDE SYNTHESIS MARKET: COMPETITIVE BENCHMARKING OF START-UP/SME PLAYERS
  • 10.9 COMPETITIVE SCENARIO AND TRENDS
    • 10.9.1 PRODUCT LAUNCHES
    • TABLE 221 PEPTIDE SYNTHESIS MARKET: PRODUCT LAUNCHES, JANUARY 2020-JUNE 2023
    • 10.9.2 DEALS
    • TABLE 222 PEPTIDE SYNTHESIS MARKET: DEALS, JANUARY 2020-JUNE 2023
    • 10.9.3 OTHER DEVELOPMENTS
    • TABLE 223 PEPTIDE SYNTHESIS MARKET: OTHER DEVELOPMENTS, JANUARY 2020-JUNE 2023

11 COMPANY PROFILES

  • 11.1 KEY PLAYERS

(Business Overview, Products & Services offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))**

    • 11.1.1 THERMO FISHER SCIENTIFIC
    • TABLE 224 THERMO FISHER SCIENTIFIC: BUSINESS OVERVIEW
    • FIGURE 34 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2022)
    • 11.1.2 MERCK KGAA
    • TABLE 225 MERCK KGAA: BUSINESS OVERVIEW
    • FIGURE 35 MERCK KGAA: COMPANY SNAPSHOT (2022)
    • 11.1.3 GENSCRIPT BIOTECH CORPORATION
    • TABLE 226 GENSCRIPT BIOTECH CORPORATION: BUSINESS OVERVIEW
    • FIGURE 36 GENSCRIPT BIOTECH CORPORATION: COMPANY SNAPSHOT (2022)
    • 11.1.4 BACHEM HOLDING AG
    • TABLE 227 BACHEM HOLDING AG: BUSINESS OVERVIEW
    • FIGURE 37 BACHEM HOLDING AG: COMPANY SNAPSHOT (2022)
    • 11.1.5 KANEKA CORPORATION
    • TABLE 228 KANEKA CORPORATION: BUSINESS OVERVIEW
    • FIGURE 38 KANEKA CORPORATION: COMPANY SNAPSHOT (2022)
    • 11.1.6 BIOTAGE AB
    • TABLE 229 BIOTAGE AB: BUSINESS OVERVIEW
    • FIGURE 39 BIOTAGE AB: COMPANY SNAPSHOT (2022)
    • 11.1.7 SYNGENE INTERNATIONAL LIMITED
    • TABLE 230 SYNGENE INTERNATIONAL LIMITED: BUSINESS OVERVIEW
    • FIGURE 40 SYNGENE INTERNATIONAL LIMITED: COMPANY SNAPSHOT (2022)
    • 11.1.8 MESA LABORATORIES, INC.
    • TABLE 231 MESA LABORATORIES, INC.: BUSINESS OVERVIEW
    • FIGURE 41 MESA LABORATORIES, INC.: COMPANY SNAPSHOT (2022)
    • 11.1.9 CEM CORPORATION
    • TABLE 232 CEM CORPORATION: BUSINESS OVERVIEW
    • 11.1.10 PROTEOGENIX
    • TABLE 233 PROTEOGENIX: BUSINESS OVERVIEW
    • 11.1.11 BIO-SYNTHESIS INC.
    • TABLE 234 BIO-SYNTHESIS INC.: BUSINESS OVERVIEW
    • 11.1.12 DALTON PHARMA SERVICES
    • TABLE 235 DALTON PHARMA SERVICES: BUSINESS OVERVIEW
    • 11.1.13 AAPPTEC
    • TABLE 236 AAPPTEC: BUSINESS OVERVIEW
    • 11.1.14 VIVITIDE
    • TABLE 237 VIVITIDE: BUSINESS OVERVIEW
    • 11.1.15 ANYGEN CO., LTD.
    • TABLE 238 ANYGEN CO., LTD.: BUSINESS OVERVIEW
  • 11.2 OTHER PLAYERS
    • 11.2.1 CSBIO
    • 11.2.2 ADVANCED CHEMTECH
    • 11.2.3 LUXEMBOURG BIO TECHNOLOGIES LTD.
    • 11.2.4 JPT PEPTIDE TECHNOLOGIES GMBH
    • 11.2.5 AMBIOPHARM INC.
    • 11.2.6 AURIGENE PHARMACEUTICAL SERVICES LTD.
    • 11.2.7 CORDENPHARMA INTERNATIONAL
    • 11.2.8 CHEMPEP INC.
    • 11.2.9 CPC SCIENTIFIC INC.
    • 11.2.10 PUROLITE PVT. LTD.
  • *Details on Business Overview, Products & Services offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

12 APPENDIX

  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3 CUSTOMIZATION OPTIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS